MedTrace Logo

CBT4CBT for Office Based Buprenorphine

NCT03580902 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2023-01-04

No results posted yet for this study

Summary

In this Phase II SBIR/STTR project, our Specific Aim will be to determine if the use of CBT4CBT-Buprenorphine leads to clinically significant improved outcomes and increased retention for buprenorphine maintenance patients in a larger and diverse population of individuals seeking buprenorphine treatment in primary care (N=100).

Conditions

  • Opioid-use Disorder

Interventions

BEHAVIORAL

CBT4CBT-Buprenorphine

Computerized, user-driven cognitive-behavioral therapy (CBT) web-based program adapted for use in office based buprenorphine treatment

DRUG

Buprenorphine/naloxone

Standard outpatient buprenorphine maintenance

Sponsors & Collaborators

  • CBT4CBT, LLC

    lead INDUSTRY

Principal Investigators

  • Julia Shi, MD · APT Foundation, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-22
Primary Completion
2021-11-23
Completion
2022-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03580902 on ClinicalTrials.gov